STRATEGY

U.S. organizational design and integration of all commercial positions for a <$20US million dollar emerging pharmaceutical organization.
Development of commercialization strategy for launch of a rare disease franchise within a $5.47€ billion global pharmaceutical company.

Launch plan, SFE (segmentation, targeting, territory design), forecast, and budget development/execution for new product competing in a $100US Million dollar therapeutic area.
1yr/5yr commercial strategic mapping; scientific & PR messaging platform; and, treatment flow and patient journey mapping for two product franchise within a ~$2US billion dollar global biotechnology company.

COMMERCIAL SERVICES (STAFF AUGMENTATION)

Joint Steering Committee Member, Marketing and sales lead for <$20US million dollar emerging pharmaceutical organization. Serving for 1.5 years overseeing the joint venture with an established oncology company; contributing to business development and licensing strategy; and successfully launching a 505(b)2 asset.
Interim VP Marketing for emerging medical device company. Serving for eight months managing marketing/sales strategy and tactical execution.

Launch Lead for US biosimilar portfolio of >$100US billion dollar global pharmaceutical company. Serving for two years, leading and facilitating the core and extended commercial launch planning teams through four indication launches.
Interim General Manager for established integrated speciality pharmaceutical company. Serving for six months, developing rules of engagement, ‘ways of working together’ for co-promote partnership, and advising the c-suite on various operational issues.